Histone deacetylase inhibition and dietary short-chain Fatty acids.

ISRN allergy Pub Date : 2011-12-26 Print Date: 2011-01-01 DOI:10.5402/2011/869647
Paul V Licciardi, Katherine Ververis, Tom C Karagiannis
{"title":"Histone deacetylase inhibition and dietary short-chain Fatty acids.","authors":"Paul V Licciardi,&nbsp;Katherine Ververis,&nbsp;Tom C Karagiannis","doi":"10.5402/2011/869647","DOIUrl":null,"url":null,"abstract":"<p><p>Changes in diet can also have dramatic effects on the composition of gut microbiota. Commensal bacteria of the gastrointestinal tract are critical regulators of health and disease by protecting against pathogen encounter whilst also maintaining immune tolerance to certain allergens. Moreover, consumption of fibre and vegetables typical of a non-Western diet generates substantial quantities of short-chain fatty acids (SCFAs) which have potent anti-inflammatory properties. Dietary interventions such as probiotic supplementation have been investigated for their pleiotropic effects on microbiota composition and immune function. Probiotics may restore intestinal dysbiosis and improve clinical disease through elevated SCFA levels in the intestine. Although the precise mechanisms by which such dietary factors mediate these effects, SCFA metabolites such as butyrate also function as histone deacetylase inhibitors (HDACi), that can act on the epigenome through chromatin remodeling changes. The aim of this review is to provide an overview of HDAC enzymes and to discuss the biological effects of HDACi. Further, we discuss the important relationship between diet and the balance between health and disease and how novel dietary interventions such as probiotics could be alternative approach for the prevention and/or treatment of chronic inflammatory disease through modulation of the intestinal microbiome.</p>","PeriodicalId":89782,"journal":{"name":"ISRN allergy","volume":"2011 ","pages":"869647"},"PeriodicalIF":0.0000,"publicationDate":"2011-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/869647","citationCount":"72","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5402/2011/869647","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2011/1/1 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 72

Abstract

Changes in diet can also have dramatic effects on the composition of gut microbiota. Commensal bacteria of the gastrointestinal tract are critical regulators of health and disease by protecting against pathogen encounter whilst also maintaining immune tolerance to certain allergens. Moreover, consumption of fibre and vegetables typical of a non-Western diet generates substantial quantities of short-chain fatty acids (SCFAs) which have potent anti-inflammatory properties. Dietary interventions such as probiotic supplementation have been investigated for their pleiotropic effects on microbiota composition and immune function. Probiotics may restore intestinal dysbiosis and improve clinical disease through elevated SCFA levels in the intestine. Although the precise mechanisms by which such dietary factors mediate these effects, SCFA metabolites such as butyrate also function as histone deacetylase inhibitors (HDACi), that can act on the epigenome through chromatin remodeling changes. The aim of this review is to provide an overview of HDAC enzymes and to discuss the biological effects of HDACi. Further, we discuss the important relationship between diet and the balance between health and disease and how novel dietary interventions such as probiotics could be alternative approach for the prevention and/or treatment of chronic inflammatory disease through modulation of the intestinal microbiome.

Abstract Image

组蛋白去乙酰化酶抑制与膳食短链脂肪酸。
饮食的改变也会对肠道菌群的组成产生巨大的影响。胃肠道的共生菌是健康和疾病的关键调节剂,它保护机体免受病原体侵袭,同时维持对某些过敏原的免疫耐受。此外,非西方饮食中典型的纤维和蔬菜的消费会产生大量的短链脂肪酸(SCFAs),它具有有效的抗炎特性。膳食干预如补充益生菌已被研究其对微生物群组成和免疫功能的多效性影响。益生菌可以通过提高肠道内SCFA水平来恢复肠道生态失调和改善临床疾病。虽然这些饮食因素介导这些影响的确切机制,但SCFA代谢物如丁酸盐也具有组蛋白去乙酰化酶抑制剂(HDACi)的功能,可以通过染色质重塑改变作用于表观基因组。本文综述了HDAC酶的研究概况,并对HDAC的生物学作用进行了探讨。此外,我们还讨论了饮食与健康和疾病之间平衡的重要关系,以及益生菌等新型饮食干预如何通过调节肠道微生物群成为预防和/或治疗慢性炎症性疾病的替代方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信